These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 27349770)

  • 61. Medical countermeasures for unwanted CBRN exposures: Part I chemical and biological threats with review of recent countermeasure patents.
    Singh VK; Garcia M; Wise SY; Seed TM
    Expert Opin Ther Pat; 2016 Dec; 26(12):1431-1447. PubMed ID: 27599259
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Current and emerging strategies for organophosphate decontamination: special focus on hyperstable enzymes.
    Jacquet P; Daudé D; Bzdrenga J; Masson P; Elias M; Chabrière E
    Environ Sci Pollut Res Int; 2016 May; 23(9):8200-18. PubMed ID: 26832878
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Small-scale purification of butyrylcholinesterase from human plasma and implementation of a μLC-UV/ESI MS/MS method to detect its organophosphorus adducts.
    John H; Breyer F; Schmidt C; Mizaikoff B; Worek F; Thiermann H
    Drug Test Anal; 2015 Oct; 7(10):947-56. PubMed ID: 25828536
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Respiratory complications of organophosphorus nerve agent and insecticide poisoning. Implications for respiratory and critical care.
    Hulse EJ; Davies JO; Simpson AJ; Sciuto AM; Eddleston M
    Am J Respir Crit Care Med; 2014 Dec; 190(12):1342-54. PubMed ID: 25419614
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Magnetic electrochemical sensing platform for biomonitoring of exposure to organophosphorus pesticides and nerve agents based on simultaneous measurement of total enzyme amount and enzyme activity.
    Du D; Wang J; Wang L; Lu D; Smith JN; Timchalk C; Lin Y
    Anal Chem; 2011 May; 83(10):3770-7. PubMed ID: 21462919
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Metal oxide nanoparticles for the decontamination of toxic chemical and biological compounds.
    Denet E; Espina-Benitez MB; Pitault I; Pollet T; Blaha D; Bolzinger MA; Rodriguez-Nava V; Briançon S
    Int J Pharm; 2020 Jun; 583():119373. PubMed ID: 32339629
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Zebrafish Models for Human Acute Organophosphorus Poisoning.
    Faria M; Garcia-Reyero N; Padrós F; Babin PJ; Sebastián D; Cachot J; Prats E; Arick Ii M; Rial E; Knoll-Gellida A; Mathieu G; Le Bihanic F; Escalon BL; Zorzano A; Soares AM; Raldúa D
    Sci Rep; 2015 Oct; 5():15591. PubMed ID: 26489395
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Organophosphates, serine esterase inhibition, and modeling of organophosphate toxicity.
    Chambers J; Oppenheimer SF
    Toxicol Sci; 2004 Feb; 77(2):185-7. PubMed ID: 14992203
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Non-muscarinic therapeutic targets for acute organophosphorus poisoning.
    Rosenbaum C; Bird SB
    J Med Toxicol; 2010 Dec; 6(4):408-12. PubMed ID: 20532844
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Sarin exposure: a simulation case scenario.
    Eason MP
    South Med J; 2013 Jan; 106(1):55-62. PubMed ID: 23263315
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Anticonvulsant discovery through animal models of status epilepticus induced by organophosphorus nerve agents and pesticides.
    McCarren HS; McDonough JH
    Ann N Y Acad Sci; 2016 Jun; 1374(1):144-50. PubMed ID: 27258770
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Countermeasures against chemical terrorism in Japan.
    Okumura T; Seto Y; Fuse A
    Forensic Sci Int; 2013 Apr; 227(1-3):2-6. PubMed ID: 23434376
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Recent advances in evaluation of oxime efficacy in nerve agent poisoning by in vitro analysis.
    Worek F; Eyer P; Aurbek N; Szinicz L; Thiermann H
    Toxicol Appl Pharmacol; 2007 Mar; 219(2-3):226-34. PubMed ID: 17112559
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Management of Organophosphorus Poisoning.
    Bajracharya SR; Prasad PN; Ghimire R
    J Nepal Health Res Counc; 2016 Sep; 14(34):131-138. PubMed ID: 28327676
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparative protective effects of HI-6 and MMB-4 against organophosphorous nerve agent poisoning.
    Lundy PM; Hamilton MG; Sawyer TW; Mikler J
    Toxicology; 2011 Jul; 285(3):90-6. PubMed ID: 21524678
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Signs of cyclosarin-induced neurotoxicity and its pharmacological treatment with quaternary pyridinium-oximes reactivators.
    Krejcova-Kunesova G; Bartosova L; Kuca K
    Toxicology; 2005 Dec; 216(1):32-40. PubMed ID: 16126317
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Medical countermeasures to WMDs: defence research for civilian and military use.
    Hamilton MG; Lundy PM
    Toxicology; 2007 Apr; 233(1-3):8-12. PubMed ID: 17029736
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Enzymes and bioscavengers for prophylaxis and treatment of organophosphate poisoning.
    Bird SB; Dawson A; Ollis D
    Front Biosci (Schol Ed); 2010 Jan; 2(1):209-20. PubMed ID: 20036941
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Progress in acetylcholinesterase reactivators and in the treatment of organophosphorus intoxication: a patent review (2006-2016).
    Gorecki L; Korabecny J; Musilek K; Nepovimova E; Malinak D; Kucera T; Dolezal R; Jun D; Soukup O; Kuca K
    Expert Opin Ther Pat; 2017 Sep; 27(9):971-985. PubMed ID: 28569609
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Limitations and challenges in treatment of acute chemical warfare agent poisoning.
    Thiermann H; Worek F; Kehe K
    Chem Biol Interact; 2013 Dec; 206(3):435-43. PubMed ID: 24091052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.